Cardona HMÁ, Ramos GJA, Jiménez HEA, López ZBE

Language: Spanish
References: 26
Page: 48-52
PDF size: 299.82 Kb.

ABSTRACT

The giant tumor of the tendon sheath is a benign tumor arising from joint synovia, bursae and tendon sheaths. Their variable clinical presentation is related to variations in site and progression. It occurs in adult population and exceptionally in children, predominates in male gender. Clinically it presents as neoformations of the interphalangeal junction. Diagnosis is supported by imaging (magnetic resonance imaging and tomography) and by histopathological confirmation. Optimally complete resection is the principle of first-line treatment, the use of radiotherapy and biological therapy as adjuvants has been described. The prognosis is good and the recurrence rate is associated with incomplete removal of the tumor. The most common differential diagnosis is synovial cysts followed by other types of cysts and angiolipomas.

REFERENCES

1. Ackerman LV. Benign giant cell tumor of tendon sheath? Mo Med. 1948; 45: 383.

2. Kitagawa Y, Takai S. Optimal treatment for tenosynovial cell tumors of the hand. J Nippon Med Sch. 2020; 87: 184-190. doi: 10.1272/jnms.JNMS.2020_87-408.

3. Alarcón-Hernández H, Enríquez-Merino J, Novales Santa-Coloma J, Pérez-Cortés S. Tumor de células gigantes de la vaina tendinosa. Reporte de un caso. Rev Cent Dermatol Pascua. 2001; 10: 90-93.

4. Rodríguez-Acar M, Ramos-Garibay A, Domínguez-Serrato MA, Salcedo-García DL. Tumor de células gigantes de la vaina tendinosa. Rev Cent Dermatol Pascua. 2010; 19: 108-111.

5. Cevik HB, Kayahan S, Eceviz E, Gümüstas SA. Tenosynovial giant cell tumor in the hand: experience with 173 cases. J Hand Surg Asian Pac Vol. 2020; 25: 158-163. doi: 10.1142/S2424835520500174.

6. Zheng S, Lee PY, Huang Y, Wang A, Li T. Giant cell tumor of tendon sheath and tendinopathy as early features of early onset sarcoidosis. Front Pediatr. 2019; 7: 480. doi: 10.3389/fped.2019.00480.

7. Erosa-Farah MA, Cortés-Cárdenas SA, López-Iñiguez A. Tumor de células gigantes de la vaina tendinosa en la mano. Rev Esp Med Quir. 2012; 17: 146-149.

8. Díaz-González JM, Domínguez-Cherit J, López-Garza NS. Tumor de células gigantes de la vaina tendinosa: estudio retrospectivo de siete casos. Dermatologia CMQ. 2017; 15: 11-13.

9. Álvarez-Buylla Blanco M, López Amado M, Padin Seara A, Reguera Arias A. Chondroid tenosynovial giant cell tumor of the temporomandibular joint: a case report. Acta Otorrinolaringol Esp. 2021; 72:128-130.

10. Arican M, Turhan Y, Gamsizkan M. A rare localized giant cell tumor of the tendon sheath originating from the ligamentum mucosum: a case report. Jt Dis Relat Surg. 2020; 31: 149-153. doi: 10.5606/ehc.2020.72323.

11. Al-Qattan MM. Giant cell tumors of tendon sheath: classification and recurrence rate. J Hand Surg Br. 2001; 26: 72-75.

12. Kitagawa Y, Tamai K, Tsunoda R, Sawaizumi T, Takai S. Bone changes associated with soft-tissue tumors of the hand. J Nippon Med Sch. 2012; 79: 267-273.

13. Wang C, Song RR, Kuang PD, Wang LH, Zhang MM. Giant cell tumor of the tendon sheath: magnetic resonance imaging findings in 38 patients. Oncol Lett. 2017; 13: 4459-4462.

14. Sansone V, Longhino V. What's in a name? A call for consistency in the classification of tenosynovial giant cell tumour. Knee. 2018; 25: 1322-1323.

15. West RB, Rubin BP, Miller MA et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci USA. 2006; 103: 690-695.

16. Elder D, Elenitsas R, Johnson BL, Murphy GF. Lever's histopathology of the skin. Philadelphia. 11th ed. 2015, pp. 874-875.

17. Glowacki KA, Weiss AP. Giant cell tumors of tendon sheath. Hand Clin. 1995; 11: 245-253.

18. Monaghan H, Salter DM, Al-Nafussi A. Giant cell tumour of tendon sheath (localized nodular tenosynovitis): clinicopathological features of 71 cases. J Clin Pathol. 2001; 54: 404-407.

19. Ikeda K, Osamura N, Tomita K: Giant cell tumour in the tendon sheath of the hand: importance of the type of lesion. Scand J Plast Reconstr Surg Hand Surg. 2007; 41: 138-142.

20. Verspoor FGM, Mastboom MJL, Hannink G, Maki RG , Wagner A, Bompas E et al. Long-term efficacy of imatinib mesylate in patients with advanced tenosynovial giant cell tumor. Sci Rep. 2019; 9: 14551.

21. Palmerini E, Longhi A, Donati DM, Staals EL. Pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor: safety and efficacy. Expert Rev Anticancer Ther. 2020; 20: 441-445.

22. Ozben H, Coskun T. Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases. BMC Musculoskeletal Disord. 2019; 20: 457.

23. Reilly KE, Stern PJ, Dale JA. Recurrent giant cell tumors of the tendon sheath. J Hand Surg Am. 1999; 24: 1298-1302.

24. Lorea P, Van De Walle H, Kinnen L, Ledoux P, Moermans JP, Van Den Heule B. Giant cell tumours of the tendon sheath: lack of correlation between nm23-H1 expression and recurrence. J Hand Surg Br. 2004; 29: 67-70.

25. Shi J, Zheng J, Zhou X, Li Z, Chen X, Gao W et al. Risk factors associated with postoperative recurrence in patients with tenosynovial giant cell tumor of the hand: a retrospective cohort study. Ann Plast Surg. 2019; 83: 523-528.

26. Linney LS, Al-Hassani F, Pikturnaite J, Mathew B, Thornton D, Wade RG et al. Tenosynovial giant cell tumours of the hand: a multicentre case-control study. J Plast Reconstr Aesthet Surg. 2019; 72: 918-923.